Takuya Oishi
Papers
1
Total Citations
5
H-Index
1
About
Takuya Oishi is a urologic surgeon and researcher whose work focuses on optimizing surgical outcomes for high-risk prostate cancer, particularly through robot-assisted radical prostatectomy (RARP). His major contribution lies in comparing treatment strategies for aggressive disease: his most-cited paper (2023) retrospectively evaluated 452 patients, demonstrating that RARP combined with extended pelvic lymph-node dissection (ePLND) offers comparable oncologic control to neoadjuvant chemohormonal therapy (NCHT) while potentially reducing overtreatment. This work provides critical evidence for personalizing surgical approaches in high-risk cases, helping clinicians weigh the benefits of lymph-node dissection against systemic therapy. With 5 citations in its first year, the study has already influenced discussions on perioperative management. Oishi’s research bridges the gap between surgical technique and multimodal care, offering data-driven insights for urologists navigating complex treatment decisions. His findings underscore the importance of tailored strategies in prostate cancer, making him a rising voice in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1